Safety study of tirilazad mesylate in patients with acute ischemic stroke (Stipas)

Steve Putman, Frances Anderson, M. Rae Morrison, Paul Turtle, Barry T. Passini, Andrew N. Wilner, Fred H. Allen, Robert Adams, Betsy Carl, Carol Bueke, Fenwick T Nichols, David C Hess, Syed Hyder, Gordon Burch, Candy Foley, Don H. Bivins, James T. Wilson, Michael A. Sisk, Donald B. Nolan, William S. EliasGeorge L. Sheppard, Neil F. Crowe, Sandra Massey, Debbie Hurst, David Zontine, Kathryn H. Gustin, E. Clarke Haley, Kathy McClure, Mark Granner, Steven Wolf, Matthews Gwynn, Ray W. Mettetal, E. Clarke Haley, James C. Tomer, Gail Kongable, Sandra Wilkinson, Carolyn Apperson Hansen, Mark C. Wolff, Robert S. Gibson, James D. Bergin, Laura Truskowski, Gene Lightfoot, Angela Lightfoot, Angela Polin, Nina J. Solenski, Judy Stiteler, Gary R. Peters, William J. Bryan

Research output: Contribution to journalArticlepeer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'Safety study of tirilazad mesylate in patients with acute ischemic stroke (Stipas)'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience